These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1866554)

  • 1. Candida and Aspergillus infections in immunocompromised patients: an overview.
    Saral R
    Rev Infect Dis; 1991; 13(3):487-92. PubMed ID: 1866554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive candidiasis during granulocytopenia.
    Anaissie E; Pinczowski H
    Recent Results Cancer Res; 1993; 132():137-45. PubMed ID: 8265854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
    Castagnola E; Bucci B; Montinaro E; Viscoli C
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
    Walsh TJ; Aoki S; Mechinaud F; Bacher J; Lee J; Rubin M; Pizzo PA
    J Infect Dis; 1990 Apr; 161(4):755-60. PubMed ID: 2138654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fungal infections in children with malignant disease].
    Michel G
    Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
    Viviani MA; Tortorano AM; Malaspina C; Colledan M; Paone G; Rossi G; Bordone G; Pagano A
    Eur J Epidemiol; 1992 May; 8(3):433-6. PubMed ID: 1397207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases.
    Walsh TJ; Lee JW; Roilides E; Francis P; Bacher J; Lyman CA; Pizzo PA
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S139-47. PubMed ID: 1562687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of systemic mycoses in immunodeficiency].
    Just-Nübling G; Stille W
    Immun Infekt; 1991 Aug; 19(4):116-20. PubMed ID: 1937558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
    Walsh TJ; Lee JW; Lecciones J; Kelly P; Peter J; Thomas V; Bacher J; Pizzo PA
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1560-4. PubMed ID: 2221866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.
    Conneally E; Cafferkey MT; Daly PA; Keane CT; McCann SR
    Bone Marrow Transplant; 1990 Jun; 5(6):403-6. PubMed ID: 2196098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European experience with oral solution and intravenous itraconazole.
    Potter M
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal infections in the immunocompromised host.
    Stein DK; Sugar AM
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):221S-228S. PubMed ID: 2686923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts.
    Walsh TJ; Lee J; Aoki S; Mechinaud F; Bacher J; Lecciones J; Thomas V; Rubin M; Pizzo PA
    Rev Infect Dis; 1990; 12 Suppl 3():S307-17. PubMed ID: 2184509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of invasive fungal infections in patients with neoplastic disease.
    Walsh TJ; Lee JW
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S468-80. PubMed ID: 8274613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
    Atkinson BA; Bouthet C; Bocanegra R; Correa A; Luther MF; Graybill JR
    J Antimicrob Chemother; 1995 May; 35(5):631-40. PubMed ID: 7592176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal infections in the immunocompromised host.
    Hawkins C; Armstrong D
    Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
    Wingard JR
    Leuk Lymphoma; 1992 Nov; 8(4-5):353-9. PubMed ID: 1290959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.